Nine OTC Markets Issuers Uplist to Nasdaq & NYSE in June 2018
Nine issuers uplisted from the OTC Markets to the NASDAQ or NYSE American in June 2018. Learn more about these OTC ‘graduates’ below.
Ambow Education Holding Ltd. (NYSE American: AMBO)
On June 1, 2018, AMBO uplisted from the OTC to the NYSE American. Ambow Education Holding Ltd. is a leading national provider of educational and career enhancement services in China, offering high-quality, individualized services and products.
Upon uplisting to the NYSE American, AMBO closed a $7,650,000 public offering. The Benchmark Company, LLC acted as the sole book-running manager and representative of the underwriters of this offering.
IMV Inc. (Nasdaq: IMV)
On June 1, 2018, IMV uplisted from the OTCQX to the Nasdaq. IMV Inc. is a clinical stage biopharmaceutical company dedicated to making immunotherapy more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases.
Oncolytics Biotech Inc. (Nasdaq: ONCY)
On June 1, 2018, ONCY uplisted from the OTCQX to the Nasdaq Capital Market. Oncolytics is a biotechnology company developing REOLYSIN, also known as pelareorep, an intravenously delivered immuno-oncolytic virus.
Upon uplisting to the Nasdaq, ONCY completed a $8.9 million public offering. Ladenburg Thalmann & Co., acted as the sole book-running manager in connection with the Offering.
comScore, Inc. (Nasdaq: SCOR)
On June 1, 2018, SCOR uplisted from the OTCPINK to the Nasdaq Global Select Market. comScore is a leading cross-platform measurement company that measures audiences, brands and consumer behavior everywhere. Built on precision and innovation, our data footprint combines proprietary digital, TV and movie intelligence with vast demographic details to quantify consumers’ multiscreen behavior at massive scale.
Command Center, Inc. (Nasdaq: CCNI)
On June 6, 2018, CCNI uplisted from the OTCQB to the Nasdaq Capital Market. Command Center provides flexible on-demand employment solutions to businesses in the United States, primarily in the areas of light industrial, hospitality and event services.
Greenpro Capital Corp. (Nasdaq: GRNQ)
On June 13, 2018, GRNQ uplisted from the OTCQB to the Nasdaq Capital Market. GreenPro Capital Corp. is one of the fastest growing financial services company in Asia Pacific.
Upon uplisting to the Nasdaq, GRNQ closed a public offering of $3.2 million. Network 1 Financial Securities, Inc. acted as the placement agent for the offering.
OptimizeRx Corp. (Nasdaq: OPRX)
On June 22, 2018, OPRX uplisted from the OTCQB to the Nasdaq Capital Market. OptimizeRx is one of the nation’s leading providers of digital health messaging via electronic health records (EHRs), providing a direct channel for pharma companies to communicate with healthcare providers.
One month prior to uplisting, OPRX completed a $9 million private placement. Lake Street Capital Markets acted as the sole placement agent, and B. Riley FBR and ROTH Capital Partners acted as advisors to the transaction.
Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO)
On June 26, 2018, ARPO uplisted from the OTCQB to the Nasdaq Capital Market. Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases.
In connection with the uplist to the Nasdaq, ARPO completed a $40 million public offering. Guggenheim Securities acted as book-running manager for the offering. Needham & Company acted as lead manager, and National Securities Corporation and H.C. Wainwright & Co. acted as co-managers for the offering.
Titan Medical Inc. (Nasdaq: TMDI)
On June 27, 2018, TMDI uplisted from the OTCQB to the Nasdaq. Titan Medical Inc. is focused on research and development through to the planned commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery.